Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Antiviral Res. 2019 Jul 24;170:104567. doi: 10.1016/j.antiviral.2019.104567

Table 1:

Detection and relative quantification of EBOV GP gene expression in EBOV-infected vaginal epithelial cells.

Sample Replicate 18s RNA EBOV
Average Ct Average Ct
No virus-No PPCM 1 13.47 32.66 Cut-off positive samples (Average ΔCt)= 18.93
2 13.39 32.31
3 13.69 32.37
Fold-change compared to cut-off (2^−ΔΔct) Sample result compared to cut-off
EBOV-No PPCM 1 14.37 22.88 1368.00 +
2 13.31 23.40 458.00 +
3 13.56 23.45 527.00 +
Fold-change compared to cut-off (2^−ΔΔct) Sample result compared to cut-off Fold-change compared to calibrator Virus-No PPCM (2^−ΔΔct). Calibrator (Average ΔCt) = 9.50
EBOV-500 ng/μl PPCM 1 13.87 32.84 0.97 NA
2 14.21 32.86 1.22 + 1.77 10−3
3 14.34 33.13 1.10 + 1.60 10−3
EBOV-50 ng/μl PPCM 1 13.61 32.85 0.81 NA
2 13.90 33.43 0.66 NA
3 13.30 32.50 0.83 NA
EBOV-5 ng/μl PPCM 1 13.30 32.41 0.88 NA
2 13.34 32.29 0.99 NA
3 13.97 32.25 1.57 + 2.27 10−3

+: virus genome positive; −: virus genome negative; NA: non-applicable